Detalles de la búsqueda
1.
Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study.
Haematologica
; 2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855069
2.
Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report.
Br J Haematol
; 189(4): 689-693, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31994178
3.
An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results.
Am J Hematol
; 97(8): E281-E284, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35560253
Resultados
1 -
3
de 3
1
Próxima >
>>